[timeout:300][out:json];
(
node(around:1000,51.74938,-1.21567)[building=commercial][~"^(addr:housenumber|.*name.*)$"~".",i];
way(around:1000,51.74938,-1.21567)[building=commercial][~"^(addr:housenumber|.*name.*)$"~".",i];
rel(around:1000,51.74938,-1.21567)[building=commercial][~"^(addr:housenumber|.*name.*)$"~".",i];
node(around:1000,51.74938,-1.21567)[landuse=industrial][name];
way(around:1000,51.74938,-1.21567)[landuse=industrial][name];
rel(around:1000,51.74938,-1.21567)[landuse=industrial][name];
);
out center tags;
The Oxford Vaccine Group (OVG) is a vaccine research group within the Department of Paediatrics at the University of Oxford. It was founded in 1994 by Professor E. Richard Moxon, was initially based at the John Radcliffe Hospital, and moved in 2003 to its current location in the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) at the Churchill Hospital in Oxford, England. The group, led by Professor Andrew Pollard since 2001, comprises around 75 members across a number of disciplines, including consultants in paediatrics and vaccinology, clinical research fellows, research nurses, statisticians, post-doctoral laboratory scientists, research assistants and DPhil students.
Die Oxford Vaccine Group (OVG) ist eine Forschungseinheit in der Abteilung für Kinderheilkunde der University of Oxford in England. Sie arbeitet unter anderem mit dem Jenner Institute der Universität Oxford zusammen und befindet sich im Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), dem Zentrum für klinische Impfstoffforschung und Tropenmedizin des Churchill Hospital in Headington, einem Vorort von Oxford.
no matches found
| Clinical trial organizations | building=commercial, landuse=industrial |